Biotechnology

Filter

Current filters:

None

Popular Filters

54 to 78 of 2383 results

Norgine provides over $8 million to Azanta to fund clinical development pipeline

Norgine provides over $8 million to Azanta to fund clinical development pipeline

13-10-2014

Norgine Ventures, the business entity of privately-owned European pharma company Norgine, has provided…

Azanta DanmarkBiotechnologyBusiness FinanceDenmarkNorgine

SOBI and Pharming extend and amend Ruconest agreement

SOBI and Pharming extend and amend Ruconest agreement

13-10-2014

Biotech companies Pharming Group and Swedish Orphan Biovitrum have amended and extended the Ruconest…

BiotechnologyHematologyMarkets & MarketingPharmingRuconestSobiSweden

FDA approves Gilead’s Harvoni, the first combo pill for hepatitis C

FDA approves Gilead’s Harvoni, the first combo pill for hepatitis C

12-10-2014

As was largely expected, the US Food and Drug Administration on Friday approved biotech firm Gilead Sciences’…

Anti-viralsBiotechnologyGilead SciencesHarvoniPricingRegulationSovaldiUSA

After nine years, AstraZeneca finally ditches Targacept

12-10-2014

On October 8, 2014, Anglo-Swedish pharma major AstraZeneca finally terminated its collaborative research…

AstraZenecaBiotechnologyGenito-urinaryLicensingNeurologicalTargacept

Biogen Idec files for Elocta approval in Europe

Biogen Idec files for Elocta approval in Europe

10-10-2014

US biotech firm Biogen Idec has submitted a Marketing Authorization Application (MAA) for Elocta (rFVIIIFc;…

Biogen IdecBiotechnologyEloctaEloctateEuropeHematologyRegulationSwedish Orphan Biovitrum

Biotron Phase II trial of BIT225 shows undetectable levels of hepatitis C 12 weeks after finishing treatment

Biotron Phase II trial of BIT225 shows undetectable levels of hepatitis C 12 weeks after finishing treatment

10-10-2014

All hepatitis C genotype 3 patients in a Phase II trial of BIT225, developed by Australian drug developer…

AustraliaBiotechnologyBiotronBIT225Nephrology and HepatologyResearch

DelMar's lead compound VAL-083 data shows potential to be superior to current treatments in NSCLC

DelMar's lead compound VAL-083 data shows potential to be superior to current treatments in NSCLC

10-10-2014

Clinical stage oncology company DelMar Pharmaceuticals’ lead drug compound VAL-083 has demonstrated…

BiotechnologyDelMar PharmaceuticalsOncologyResearchUSAVAL-083

US orphan designation for DNAtrix’ DNX-2401 in malignant glioma

US orphan designation for DNAtrix’ DNX-2401 in malignant glioma

09-10-2014

US privately-held oncolytic virus expert DNAtrix says that the US Food and Drug Administration has granted…

BiotechnologyDNAtrixDNX-2401OncologyRegulationUSA

Roche acquires exclusive rights to AbVitro's extension-based target enrichment technology

Roche acquires exclusive rights to AbVitro's extension-based target enrichment technology

09-10-2014

Swiss drug major Roche has acquired exclusive rights to a primer extension-based target enrichment technology…

AbVitroBiotechnologyLicensingRocheSwitzerland

Chimerix reports preliminary data showing antiviral brincidofovir improves survival in adenovirus

Chimerix reports preliminary data showing antiviral brincidofovir improves survival in adenovirus

09-10-2014

Antiviral biopharma company Chimerix has reported preliminary data indicating that its investigational…

Anti-viralsBiotechnologybrincidofovirChimerixResearchUSA

UK Bioscience Forum: Incentivize investors to hold their investment for more than 10 years

UK Bioscience Forum: Incentivize investors to hold their investment for more than 10 years

08-10-2014

One of the main messages from the keynote speech at the UK Bioscience Forum by Paul Drayson, chief executive…

BiotechnologyLegalLicensingPatents & Trade marksProductionRegulationResearchSocial IssuesUK

Biotherapies could save millions of euros when treating auto-immune diseases

Biotherapies could save millions of euros when treating auto-immune diseases

08-10-2014

Health care providers could save millions of euros if biotherapies were used in the treatment of Crohn’s…

Anti-Arthritics/RheumaticsBiotechnologyEuropeFinancialHealthcareResearchTheradiag

Cardio3 Biosciences gains preferred access to all Mayo Clinic regenerative medicine portfolio

Cardio3 Biosciences gains preferred access to all Mayo Clinic regenerative medicine portfolio

08-10-2014

Belgium biotech firm Cardio3 BioSciences says it has signed a preferred access agreement with the USA’s…

BelgiumBiotechnologyC-CureCardio-vascularCardio3 BioSciencesResearchUSA

US FDA grants Fast Track status to BrainStorm Cell Therapeutics for ALS treatment NurOwn

US FDA grants Fast Track status to BrainStorm Cell Therapeutics for ALS treatment NurOwn

07-10-2014

The US Food and Drug Administration has designated a product from stem cell treatment developer BrainStorm…

BiotechnologyBrainStorm Cell TherapeuticsNeurologicalNurOwnRegulationUSA

Merck Serono links with ICR and Wellcome Trust on anti-cancer drugs

Merck Serono links with ICR and Wellcome Trust on anti-cancer drugs

07-10-2014

German life sciences major Merck KGaA says its biopharma division Merck Serono has entered into a co-development…

BiotechnologyGermanyLicensingMerck KGaAMerck SeronoOncologyResearch

Regeneron gains further FDA indications for Eylea

Regeneron gains further FDA indications for Eylea

07-10-2014

The US Food and Drug Administration has approved biotech firm Regeneron Pharmaceuticals’ Eylea (aflibercept)…

BayerBiotechnologyEyleaOphthalmicsRegeneron PharmaceuticalsRegulationUSA

CleveXel Pharma licenses two new oncology patents from SATT Sud Est

CleveXel Pharma licenses two new oncology patents from SATT Sud Est

06-10-2014

French company CleveXel Pharma has been granted a license by the SATT Sud Est, a technology transfer…

BiotechnologyCleveXel PharmaFranceLicensingOncologyPatentsSATT Sud Est

PDL BioPharma appoints Danny Hart as vice president of business development

PDL BioPharma appoints Danny Hart as vice president of business development

06-10-2014

PDL BioPharma has appointed Danny Hart as vice president of business development.

BiotechnologyBoardroomDanny HartPDL BioPharmaUSA

54 to 78 of 2383 results

Parexel

Parexel

Back to top